Join us Sept. 14-16 in Miami to connect with top publishing leaders
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
‘Inside, most of them are dumpster fires’: Confessions of a frustrated indie agency ad exec
From surprise corporate card cancellations to phantom return-to-office mandates, one former indie agency exec talks about the chaos behind the scenes.
The case for and against the ‘programmatic-ification’ of the creator economy
Creator marketing is racing toward AI ad-stack automation, but risks turning trust into inventory.
Digiday+ Research: The marketers’ 2026 guide to retail media marketing, including The Home Depot, Milani Cosmetics and Tinuiti
As the retail media landscape continues to evolve, marketers are rethinking where they invest, how they measure success and which retail media networks deserve a larger share of budget.